Literature DB >> 17522890

Hodgkin's lymphoma in a patient with Jo-1 syndrome.

Alexander C Adam1, Christian Grohé, Sebastian Stier, Stefan Gattenlöhner, Zeynep Balta, Reinhard Büttner, Ines Gütgemann.   

Abstract

Jo-1 syndrome is an autoimmune disease with autoantibodies against the histidyl tRNA synthetase. Characteristic clinical findings include inflammatory myopathy and interstitial lung disease. We present the first case of a patient with Jo-1 syndrome (positive Jo-1 autoantibodies, myositis, interstitial alveolitis) who developed Hodgkin's lymphoma of nodular-sclerosing type. Thus, patients with Jo-1 syndrome and immunosuppressive therapy similar to other patients with autoimmune disease are at risk to develop lymphomas and should therefore be monitored carefully.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17522890     DOI: 10.1007/s00428-007-0429-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  10 in total

1.  The Epstein-Barr virus in malignant non-Hodgkin's lymphoma of the upper aerodigestive tract.

Authors:  G Ott; J Kalla; M M Ott; H K Müller-Hermelink
Journal:  Diagn Mol Pathol       Date:  1997-06

Review 2.  Epstein-Barr virus-associated Hodgkin's lymphoma.

Authors:  Maher K Gandhi; Judy T Tellam; Rajiv Khanna
Journal:  Br J Haematol       Date:  2004-05       Impact factor: 6.998

Review 3.  Jo-1 syndrome with associated poorly differentiated adenocarcinoma.

Authors:  J Watkins; R Farzaneh-Far; H Tahir; F Wykes; P R Studdy; H L C Beynon
Journal:  Rheumatology (Oxford)       Date:  2004-03       Impact factor: 7.580

Review 4.  Polymyositis, dermatomyositis and inclusion-body myositis.

Authors:  M C Dalakas
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

5.  Detection of T-cell clonality in paraffin-embedded tissues.

Authors:  J Lorenzen; G Jux; M Zhao-Höhn; A Klöckner; R Fischer; M L Hansmann
Journal:  Diagn Mol Pathol       Date:  1994-06

Review 6.  The risk of lymphoma development in autoimmune diseases: a meta-analysis.

Authors:  Elias Zintzaras; Michael Voulgarelis; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2005-11-14

7.  Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.

Authors:  Margaret L Gulley; Sally L Glaser; Fiona E Craig; Michael Borowitz; Risa B Mann; Sarah J Shema; Richard F Ambinder
Journal:  Am J Clin Pathol       Date:  2002-02       Impact factor: 2.493

Review 8.  NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy.

Authors:  P H Plotz; L G Rider; I N Targoff; N Raben; T P O'Hanlon; F W Miller
Journal:  Ann Intern Med       Date:  1995-05-01       Impact factor: 25.391

9.  A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.

Authors:  L A Love; R L Leff; D D Fraser; I N Targoff; M Dalakas; P H Plotz; F W Miller
Journal:  Medicine (Baltimore)       Date:  1991-11       Impact factor: 1.889

10.  [A case of interstitial pneumonitis associated with polymyositis complicated by renal cell carcinoma].

Authors:  Y Iwasaki; T Mohri; M Muraki; A Yasukawa; T Fujimoto; O Takagi; Y Tsuya; S Nakajima
Journal:  Nihon Kyobu Shikkan Gakkai Zasshi       Date:  1992-10
  10 in total
  1 in total

1.  An Unusual Suspect Causing Hypoxemic Respiratory Failure.

Authors:  Masooma Aqeel; Bjorn Batdorf; Horatiu Olteanu; Jayshil J Patel
Journal:  J Investig Med High Impact Case Rep       Date:  2017-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.